A Multi-centre, Multinational, Prospective Observational Registry to Collect Safety and Outcome Data in Patients Diagnosed With Severe Hepatic Veno-occlusive Disease (VOD) Following Hematopoietic Stem Cell Transplantation (HSCT) and Treated With Defitelio
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 18 Feb 2019
At a glance
- Drugs Defibrotide (Primary)
- Indications Veno-occlusive disorders
- Focus Adverse reactions
- 12 Feb 2019 Planned End Date changed from 17 Jul 2019 to 1 Jul 2019.
- 12 Feb 2019 Planned primary completion date changed from 17 Jul 2019 to 1 Jul 2019.
- 23 Jul 2018 Planned End Date changed from 1 Dec 2018 to 17 Jul 2019.